Melatonin Use in Hospitalized Children for Non-Anesthetic Indications: A Systematic Review

David E Procaccini1, Katie Lobner2, Blair Anton2

  • 1Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland, USA.

Pharmacotherapy
|April 29, 2020
PubMed

Insights

Melatonin supplementation appears safe for hospitalized neonates, potentially reducing inflammation. However, more research is needed in diverse pediatric populations for non-sedative uses.

Area of Science:

  • Biomedical Sciences
  • Pediatric Medicine
  • Pharmacology

Background:

  • Melatonin is a free radical scavenger crucial for physiological homeostasis.
  • Increased melatonin synthesis during oxidative stress suggests therapeutic potential during acute illness.
  • Limited pediatric studies hinder safe melatonin use for non-anesthetic indications.

Purpose of the Study:

  • To systematically review studies on melatonin use in hospitalized pediatric patients for non-sedative and non-analgesic indications.
  • To assess the safety and potential benefits of melatonin in this population.

Main Methods:

  • Searched major biomedical databases (PubMed, EMBASE, CINAHL, Web of Science, Scopus).
  • Included 13 eligible studies, all focusing on neonates.
  • Extracted data on study design, patient numbers, indications, and melatonin regimens.
  • Categorized studies by indication: antioxidant/anti-inflammatory therapy in infections, respiratory distress syndrome, neurologic injury, and jaundice.

Main Results:

  • All identified studies involved neonates.
  • Melatonin demonstrated safety in hospitalized neonates.
  • Evidence suggests potential benefits in reducing inflammatory markers for conditions linked to oxidative stress.
  • Melatonin with phototherapy was not superior to vitamin D with phototherapy for neonatal jaundice.

Conclusions:

  • Current data indicate melatonin is safe for hospitalized neonates.
  • Melatonin may offer anti-inflammatory benefits in neonatal conditions involving oxidative stress.
  • Further research in broader pediatric populations is essential due to widespread clinical use.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
437
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
414
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.2K
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
346
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
148
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
386